Finance

Lists
Why is 4598 down 5.26%?
Dive Deeper
4598:TYO
Delta-Fly Pharma Inc
¥90.00
-5.26%
(-5.00) 1D
Oct 14, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4598...
Open
¥95
High
¥95
Low
¥90
Mkt. cap
1.74B
Avg. vol.
2.34M
Volume
949.10K
52-wk high
¥700
52-wk low
¥90
EPS
-¥136
Shares outstanding
4.37M
No. of employees
12
Open
¥95
High
¥95
Low
¥90
Mkt. cap
1.74B
Avg. vol.
2.34M
Volume
949.10K
52-wk high
¥700
52-wk low
¥90
EPS
-¥136
Shares outstanding
4.37M
No. of employees
12
News stories
From web sources and news partners
About Delta-Fly Pharma Inc
CEO-
Employees12
FoundedDec 6, 2010
Headquarters-
SectorBiotechnology
Websitedelta-flypharma.co.jp
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
413.00M
335.00M
297.00M
365.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
60.00M
68.00M
8.00M
55.00M
Operating expense
473.00M
403.00M
371.00M
420.00M
Total operating expenses
473.00M
403.00M
371.00M
420.00M
Operating income
-473.00M
-403.00M
-371.00M
-420.00M
Other non operating income
1.00M
-4.00M
-5.00M
-1.00M
EBT including unusual items
-473.00M
-407.00M
-376.00M
-422.00M
EBT excluding unusual items
-473.00M
-407.00M
-376.00M
-422.00M
Income tax expense
1.00M
-
1.00M
-
Effective tax rate
-0.21%
-
-0.27%
-
Other operating expenses
-
-
66.00M
-
Net income
-474.00M
-407.00M
-377.00M
-422.00M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-472.75M
-402.75M
-370.75M
-419.75M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps